IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Stonepine Capital Management, LLC

Q2 2020 Holdings

Filed 2020-08-13 | 13 holdings | $2.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cumberland Pharmaceuticals(CPIX)COM230770109$2.3M676,59297.9%
Iveric BIO Inc(OPHTEUR)COM46583P102$14.0K2,739,6410.6%
Ligand Pharmaceuticals(LGND)COM NEW53220K504$10.3K92,4070.4%
CTI Biopharma Corp(CTIC1USD)COM12648L601$4.7K4,068,1910.2%
Diamedica Therapeutics Inc(DMAC)COM NEW25253X207$4.6K668,4300.2%
Catalyst Biosciences IncCOM NEW14888D208$3.2K547,5410.1%
Neos Therapeutics Inc(NEOS)COM64052L106$3.0K4,447,0260.1%
Xoma Corp(XOMA)COM NEW98419J206$3.0K150,2130.1%
Apollo Endosurgery Inc(HQ8F)COM03767D108$2.4K1,447,7650.1%
Adamas Pharmaceuticals Inc(ADMSEUR)COM00548A106$1.9K757,7040.1%
Cerecor IncCOM15671L109$1.2K450,5000.1%
Progenity IncCOM74319F107$86596,1350.0%
Brickell Biotech IncCOM10802T105$147146,7390.0%